Not Just Acid Reflux: The Need to Think Worst First
A previously healthy, well-appearing 42-year-old female living in a modern, high-rise apartment in downtown Los Angeles calls 9-1-1 at 5:30 am complaining of worsening of a burning, epigastric pain she had been experiencing for the last three days. She reports associated nausea and non-bloody, non-bilious vomiting, and that she couldn’t manage to get comfortable in bed until she finally decided to call for help at daybreak. During her 9-1-1 call, she reports “pain, like heartburn, that just woke me up again and I had to throw up, … and then I was sweating so much.” Using the Los Angeles Tiered Disp...
Source: JEMS Special Topics - January 13, 2019 Category: Emergency Medicine Authors: Stephen Sanko, MD, FACEP Tags: Exclusive Articles Cardiac & Resuscitation Source Type: news

Lidocaine Infusion for Prevention of Chronic Postsurgical Pain Lidocaine Infusion for Prevention of Chronic Postsurgical Pain
Does systemic perioperative lidocaine administration reduce the development of chronic postsurgical pain?Pain (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 11, 2019 Category: Consumer Health News Tags: Anesthesiology Journal Article Source Type: news

EMLA Cream Only Minimally Effective for Venipuncture Pain in Babies EMLA Cream Only Minimally Effective for Venipuncture Pain in Babies
For infants younger than 3 months undergoing venipuncture, eutectic mixture of lidocaine (EMLA) cream has only minimal pain relieving effects relative to placebo and no benefit over sucrose and/or breastfeeding, according to a meta-analysis of published studies.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 27, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Emla (Lidocaine and Prilocaine) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - December 17, 2018 Category: Drugs & Pharmacology Source Type: news

Switch for oral Lidocaine-containing products for teething
Commenting on news from theMedicines and Healthcare products Regulatory Agency (MHRA) that oral lidocaine products for teething babies will become pharmacy-only medicines in 2019, RPS President Ash So (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - December 14, 2018 Category: Drugs & Pharmacology Source Type: news

Non-medicinal options advised to soothe teething babies
The review by the UK-based Medicines and Healthcare products Regulatory Agency found teething gels containing lidocaine should only be used when non-medicinal options don't work. (Source: the Mail online | Health)
Source: the Mail online | Health - December 13, 2018 Category: Consumer Health News Source Type: news

Oral Lidocaine-containing products for teething in children
Oral lidocaine products authorised for teething are becoming Pharmacy medicines and additional measures will be introduced... (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - December 13, 2018 Category: Drugs & Pharmacology Source Type: news

Xylocaine (lidocaine HCl and epinephrine) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - November 27, 2018 Category: Drugs & Pharmacology Source Type: news

Xylocaine Viscous (Lidocaine Hydrochloride Solution) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - November 27, 2018 Category: Drugs & Pharmacology Source Type: news

Xylocaine (Lidocaine) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - November 27, 2018 Category: Drugs & Pharmacology Source Type: news

Xylocaine MPF Sterile Solution (Lidocaine HCl Sterile Solution) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - November 27, 2018 Category: Drugs & Pharmacology Source Type: news

Airway, Breathing or Consequences: Use Your Tools and Trust the Technology
“An esophageal intubation is no sin, but there is great sin in not recognizing such a placement.” — Special Operations Combat Medical Skills Sustainment Course (U.S. Special Operations Command) How hard is it take to properly intubate the trachea? Actually, it’s far more difficult than most people think. Recent anesthesia research shows that at least 75 live adult intubations are needed to achieve a 90% initial competency.1 Yes, 75! Not the very limited live number that are experienced in many paramedic schools, and certainly not only practicing with manikins. And how hard is it to intubate the esop...
Source: JEMS Special Topics - October 1, 2018 Category: Emergency Medicine Authors: Scott DeBoer, RN, MSN, CEN, CPEN, CCRN, CFRN, EMT-P Tags: Airway & Respiratory Exclusive Articles Source Type: news

An Update on EMS Medication Shortages
Medication shortages that affect EMS, although declining over the last eight years, have become persistent. The supply of staple drugs that are frequently used by EMS remains chronically unstable. Atropine, epinephrine, lidocaine, dextrose, fentanyl, diazepam and others reappear with frequency on the drug shortage lists around the country. Most recently, the national inventory of IV infusion bags of sodium chloride (i.e., normal saline solution) and dextrose 5%, have been affected. There are several reasons we experience these shortages. The United States Food and Drug Administration (FDA) has researched the causes of drug...
Source: JEMS Administration and Leadership - September 7, 2018 Category: Emergency Medicine Authors: Vincent D. Robbins, FACPE, FACHE Tags: Columns Exclusive Articles Administration and Leadership Operations Source Type: news

An Update on EMS Medication Shortages
Medication shortages that affect EMS, although declining over the last eight years, have become persistent. The supply of staple drugs that are frequently used by EMS remains chronically unstable. Atropine, epinephrine, lidocaine, dextrose, fentanyl, diazepam and others reappear with frequency on the drug shortage lists around the country. Most recently, the national inventory of IV infusion bags of sodium chloride (i.e., normal saline solution) and dextrose 5%, have been affected. There are several reasons we experience these shortages. The United States Food and Drug Administration (FDA) has researched the causes of drug...
Source: JEMS Operations - September 7, 2018 Category: Emergency Medicine Authors: Vincent D. Robbins, FACPE, FACHE Tags: Columns Exclusive Articles Administration and Leadership Operations Source Type: news

An Update on EMS Medication Shortages
Medication shortages that affect EMS, although declining over the last eight years, have become persistent. The supply of staple drugs that are frequently used by EMS remains chronically unstable. Atropine, epinephrine, lidocaine, dextrose, fentanyl, diazepam and others reappear with frequency on the drug shortage lists around the country. Most recently, the national inventory of IV infusion bags of sodium chloride (i.e., normal saline solution) and dextrose 5%, have been affected. There are several reasons we experience these shortages. The United States Food and Drug Administration (FDA) has researched the causes of drug...
Source: JEMS Special Topics - September 7, 2018 Category: Emergency Medicine Authors: Vincent D. Robbins, FACPE, FACHE Tags: Columns Exclusive Articles Administration and Leadership Operations Source Type: news

Lidocaine Hydrochloride (Xylocaine) Injection (Updated - Currently in Shortage)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - August 8, 2018 Category: Drugs & Pharmacology Source Type: news

Lidocaine HCl Topical Jelly (New - Discontinuation)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - April 25, 2018 Category: Drugs & Pharmacology Source Type: news

How Do You Fix A Broken Nail?
Discussion Distal digits, especially of the hand, are important as they provide support for pinching and grip, give tactile sensation and contribute to cosmesis. Trauma to the distal digit and nailbed ranges from significant trauma with digital crush injuries or amputation to minor broken nails causing only annoyance. Most injuries especially in children involve the hand especially the middle finger. The dominant hand is more common if the child has a hand-preference. Usually they occur indoors especially being caused by being pinched by a door. Significant trauma requires surgical intervention and may require specialty s...
Source: PediatricEducation.org - April 9, 2018 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Crescita Announces Launch of Pliaglis in U.S.
MISSISSAUGA, ON, March 29, 2018 -- (Healthcare Sales & Marketing Network) - Crescita Therapeutics Inc. (TSX: CTX) ("Crescita" or "the Company"), a commercial dermatology company with a portfolio of non-prescription skincare products an... Biopharmaceuticals, Dermatology, Product Launch Crescita Therapeutics, Pliaglis, lidocaine, tetracaine, dermal anaesthesia (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 29, 2018 Category: Pharmaceuticals Source Type: news

Endo, others to pay $270.8 mln to resolve Lidoderm U.S. antitrust cases
(Reuters) - Endo International Plc and two other companies have agreed to pay $270.8 million to resolve class action lawsuits alleging Endo paid a generic drug manufacturer to delay launching a cheaper version of its Lidoderm painkiller patch. (Source: Reuters: Health)
Source: Reuters: Health - March 21, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

ZTLido (Lidocaine) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - March 7, 2018 Category: Drugs & Pharmacology Source Type: news

Lidocaine Patches for Somatic Back Pain Lidocaine Patches for Somatic Back Pain
Is there evidence demonstrating that lidocaine 5% patches are effective for relief of somatic back pain?American Family Physician (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 1, 2018 Category: Consumer Health News Tags: Family Medicine/Primary Care Journal Article Source Type: news

Sorrento Therapeutics Subsidiary, Scilex, Receives FDA Approval for Non-Opioid ZTlido (lidocaine topical system) 1.8% for Post-Herpetic Neuralgia Pain
SAN DIEGO, Feb. 28, 2018 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ:SRNE) ( “Sorrento”), and its majority-owned subsidiary, Scilex Pharmaceuticals Inc. (“Scilex”), received approval from the U.S. Food and Drug Administration... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - February 28, 2018 Category: Drugs & Pharmacology Source Type: news

Sorrento Therapeutics wins FDA nod for post-shingles pain patch
Shares in Sorrento Therapeutics (NSDQ:SRNE) soared today after the company announced that the FDA approved its ZTlido lidocaine pain patch designed to treat patients with post-shingles neuralgia. The company resubmitted its application for ZTlido to the FDA last year after it was rejected by the U.S. regulatory agency in 2016. Get the full story at our sister site, Drug Delivery Business News. The post Sorrento Therapeutics wins FDA nod for post-shingles pain patch appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - February 28, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Food & Drug Administration (FDA) Pain Management Pharmaceuticals Regulatory/Compliance Wall Street Beat Sorrento Therapeutics Source Type: news

Lidocaine Hydrochloride Injection (New - Currently in Shortage)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - February 20, 2018 Category: Drugs & Pharmacology Source Type: news

Efficacy of Articaine versus Lidocaine in Supplemental Infiltration for Mandibular First versus Second Molars with Irreversible Pulpitis: A Prospective, Randomized, Double-blind Clinical Trial
ConclusionsThe success rate for IANB with 4% articaine was 25%. Articaine and lidocaine had similar success rates for supplemental infiltration in first molars, whereas articaine was significantly more successful for second molars. However, because BI often did not provide profound pulpal anesthesia, additional techniques including intraosseous anesthesia may still be required. (Source: Dental Technology Blog)
Source: Dental Technology Blog - February 16, 2018 Category: Dentistry Source Type: news

CidalEaze (Lidocaine 3% HCL Cream) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - February 1, 2018 Category: Drugs & Pharmacology Source Type: news

Low-level laser therapy and anesthetic infiltration for orofacial pain in patients with fibromyalgia: a randomized clinical trial.
CONCLUSIONS:The LLLT by GaAlAs and anesthetic infiltration of lidocaine 2% were equally effective to control orofacial pain in FM individuals. (Source: Dental Technology Blog)
Source: Dental Technology Blog - December 29, 2017 Category: Dentistry Source Type: news

Case series: treating cannabinoid hyperemesis syndrome with capsaicin cream
3 out of 5 stars Resolution of cannabis hyperemesis syndrome with topical capsaicin in the emergency department: a case series. Dezieck L et al. Clin Toxicol 2017 Sep;55:908-913. Abstract  Cannabis hyperemesis syndrome (CHS) is a form of cyclic vomiting characterized by: chronic marijuana use recurrent vomiting, and lack of alternate explanation for symptoms A striking feature is that although CHS-induced nausea and vomiting are frequently resistant to standard antiemetics such as ondansetron, patients often report that very hot showers or baths relieve their symptoms. Several years ago, Jeff Lapoint ...
Source: The Poison Review - December 5, 2017 Category: Toxicology Authors: Leon Gussow Tags: Medical cannabinoid hyperemesis syndrome capsaicin treatment TRPV1 receptor Source Type: news

Scilex seeks EU nod for ZTlido lidocaine patch
Sorrento Therapeutics (NSDQ:SRNE) subsidiary Scilex Pharmaceuticals said today that it filed a marketing authorization application seeking approval for its ZTlido lidocaine patch. The San Diego, Calif.-based company said it is pursuing a hybrid regulatory pathway with the Medicines and Healthcare Products Regulatory Agency in the U.K., which will serve as the lead review agency. The company also plans to file for review in other countries, including Germany, France, Spain, Italy and Ireland. Get the full story at our sister site, Drug Delivery Business News. The post Scilex seeks EU nod for ZTlido ...
Source: Mass Device - November 14, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Pain Management Pharmaceuticals Regulatory/Compliance Wall Street Beat Scilex Pharmaceuticals Sorrento Therapeutics Source Type: news

Ridge Properties DBA Pain Relief Naturally Issues Voluntary Nationwide Recall of all lots of Naturally HL Bedsore Cream, Pretat by TAT Balm Carbomer Free Gel, & All Naturally HL Hemorrhoid products due to manufacturing concerns at the facility
Ridge Properties DBA Pain Relief Naturally voluntarily recalls all lots within expiry of Naturally HL Bedsore Relief Cream, Extra Strength PreTAT by TAT Balm Carbomer Free Gel and Extra Strength Naturally HL Hemorrhoid Numbing with Lidocaine. (Source: NCCAM Featured Content)
Source: NCCAM Featured Content - November 9, 2017 Category: Complementary Medicine Authors: NCCIH Source Type: news

Ridge Properties DBA Pain Relief Naturally Issues Voluntary Nationwide Recall of all lots of Naturally HL Bedsore Cream, Pretat by TAT Balm Carbomer Free Gel, & All Naturally HL Hemorrhoid products due to manufacturing concerns at the facility
Ridge Properties DBA Pain Relief Naturally is voluntarily recalling all lots within expiry of Naturally HL Bedsore Relief Cream, Extra Strength PreTAT by TAT Balm Carbomer Free Gel and Extra Strength Naturally HL Hemorrhoid Numbing with Lidocaine manufactured by Ridge Properties dba Pain Relief Naturally, Salem, Oregon to the consumer level. These products are being recalled after an FDA inspection found significant violations of current good manufacturing practice regulations. (Source: Food and Drug Administration)
Source: Food and Drug Administration - November 3, 2017 Category: Food Science Source Type: news

Lidocaine Hydrochloride (Xylocaine) and Dextrose Injection Solution-Premix Bags (Updated - Currently in Shortage)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - November 2, 2017 Category: Drugs & Pharmacology Source Type: news

Lidocaine Hydrochloride (Xylocaine) and Dextrose Injection Solution-Premix Bags (New - Currently in Shortage)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - October 25, 2017 Category: Drugs & Pharmacology Source Type: news

Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine (Updated - Currently in Shortage
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - October 23, 2017 Category: Drugs & Pharmacology Source Type: news

Inserting a cannula into a vein
(Deutsches Aerzteblatt International) Patients who are given a local anesthetic before having a venous cannula inserted have a clearly reduced sensation of pain when larger gauge cannulas are used. Compared with intradermal lidocaine infusion, the use of vapocoolant spray has the advantage that the rate of venepuncture failures is lower. This is the conclusion reached by Dirk R ü sch and coauthors from Marburg University based on a randomized controlled trial. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 13, 2017 Category: International Medicine & Public Health Source Type: news

Auburn therapeutic company receives FDA drug approval
Vitruvias Therapeutics LLC, an Auburn-based drug company, has received approval of a new drug application from the U.S. Food and Drug Administration for a new drug. Vitruvias developed the drug with Sunny Pharmtech, a Taiwan-based API and drug development company. Sunny Pharmtech leaders said the jointly filed application received approval quickly. The drug, lidocaine ointment USP 5 percent, is the first generic approval for both companies and is also part o f a joint development agreement that… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - September 29, 2017 Category: Health Management Authors: Tyler Patchen Source Type: news

Auburn therapeutic company receives FDA drug approval
Vitruvias Therapeutics LLC, an Auburn-based drug company, has received approval of a new drug application from the U.S. Food and Drug Administration for a new drug. Vitruvias developed the drug with Sunny Pharmtech, a Taiwan-based API and drug development company. Sunny Pharmtech leaders said the jointly filed application received approval quickly. The drug, lidocaine ointment USP 5 percent, is the first generic approval for both companies and is also part o f a joint development agreement that… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 29, 2017 Category: Biotechnology Authors: Tyler Patchen Source Type: news

Your NEJM Group Today: Eradicating TB in U.S. / Lidocaine for IUD Insertion / Pennsylvania Internist Opportunities (FREE)
By the Editors Here's what we chose for you from NEJM Group today:NEJM Audio … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - September 21, 2017 Category: Primary Care Source Type: news

Lidocaine Nerve Block Reduces the Pain of IUD Insertion in Young Women Lidocaine Nerve Block Reduces the Pain of IUD Insertion in Young Women
Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 8, 2017 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health News Source Type: news

Sorrento Therapeutics, Inc. Submits NDA For ZTlido(TM) Next-Generation Lidocaine Patch
SAN DIEGO, Aug. 29, 2017 -- (Healthcare Sales & Marketing Network) -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE) ("Sorrento"), announced today that SCILEX Pharmaceuticals Inc. ("SCILEX"), a majority-owned subsidiary of Sorrento, resubm... Biopharmaceuticals, Drug Delivery, FDA Sorrento Therapeutics, SCILEX Pharmaceuticals, ZTlido, lidocaine patch (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 29, 2017 Category: Pharmaceuticals Source Type: news

Sorrento seeks FDA nod for lidocaine patch
Sorrento Therapeutics (NSDQ:SRNE) said today that its subsidiary Scilex Pharmaceuticals resubmitted the new drug application for its lidocaine patch, ZTlido, to the FDA. The San Diego, Calif.-based company is developing the drug-device product for the relief of pain associated with post-herpetic neuralgia. Get the full story at our sister site, Drug Delivery Business News. The post Sorrento seeks FDA nod for lidocaine patch appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - August 29, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Food & Drug Administration (FDA) Pain Management Pharmaceuticals Regulatory/Compliance Wall Street Beat Scilex Pharmaceuticals Sorrento Therapeutics Source Type: news

Sorrento Therapeutics, Inc. Submits NDA For ZTlido Next-Generation Lidocaine Patch
SAN DIEGO, Aug. 29, 2017 /PRNewswire/ -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE) ( " Sorrento " ), announced today that SCILEX Pharmaceuticals Inc. ( " SCILEX " ), a majority-owned subsidiary of Sorrento, resubmitted the NDA and responded to all of FDA... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - August 29, 2017 Category: Drugs & Pharmacology Source Type: news

Lignospan Standard (Lidocaine HCl 2% and Epinephrine Injection) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - August 10, 2017 Category: Drugs & Pharmacology Source Type: news

Lignospan Forte (Lidocaine HCl 2% and Epinephrine for Injection) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - August 9, 2017 Category: Drugs & Pharmacology Source Type: news